Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Insect | 3 | 2015 | 76 | 0.820 |
Why?
|
| Insulator Elements | 2 | 2011 | 7 | 0.450 |
Why?
|
| Drosophila melanogaster | 4 | 2015 | 613 | 0.440 |
Why?
|
| Quantitative Trait Loci | 2 | 2014 | 607 | 0.380 |
Why?
|
| Molecular Sequence Annotation | 1 | 2011 | 69 | 0.370 |
Why?
|
| Liver | 2 | 2015 | 1205 | 0.360 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 153 | 0.360 |
Why?
|
| Genome, Human | 3 | 2017 | 767 | 0.320 |
Why?
|
| Drosophila | 2 | 2015 | 521 | 0.280 |
Why?
|
| Genotype | 4 | 2021 | 1848 | 0.240 |
Why?
|
| Genome-Wide Association Study | 4 | 2021 | 1670 | 0.240 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 2399 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2014 | 79 | 0.220 |
Why?
|
| Chromosome Deletion | 2 | 2014 | 229 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2015 | 280 | 0.180 |
Why?
|
| Repressor Proteins | 3 | 2014 | 423 | 0.170 |
Why?
|
| Chromosome Mapping | 3 | 2014 | 1076 | 0.170 |
Why?
|
| Transcription Factors | 5 | 2014 | 1652 | 0.160 |
Why?
|
| Chromatin | 2 | 2012 | 397 | 0.160 |
Why?
|
| Gene Expression | 2 | 2021 | 1310 | 0.160 |
Why?
|
| Nuclear Proteins | 3 | 2014 | 726 | 0.160 |
Why?
|
| Multifactorial Inheritance | 2 | 2021 | 169 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 956 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2014 | 1096 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 2 | 2014 | 1063 | 0.140 |
Why?
|
| 3' Untranslated Regions | 2 | 2017 | 94 | 0.130 |
Why?
|
| Altitude | 1 | 2015 | 42 | 0.130 |
Why?
|
| Ovum | 1 | 2015 | 59 | 0.120 |
Why?
|
| Thyroxine-Binding Globulin | 1 | 2015 | 6 | 0.120 |
Why?
|
| Adaptation, Biological | 1 | 2015 | 85 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 866 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 2752 | 0.120 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2017 | 152 | 0.120 |
Why?
|
| Homeodomain Proteins | 3 | 2014 | 556 | 0.120 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 1429 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 2335 | 0.110 |
Why?
|
| Proteome | 1 | 2014 | 132 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2014 | 342 | 0.110 |
Why?
|
| Halomonadaceae | 1 | 2013 | 4 | 0.110 |
Why?
|
| Hemiptera | 1 | 2013 | 7 | 0.110 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2012 | 7 | 0.110 |
Why?
|
| Transfection | 2 | 2012 | 911 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 576 | 0.100 |
Why?
|
| Genes, Switch | 1 | 2012 | 8 | 0.100 |
Why?
|
| GATA2 Transcription Factor | 1 | 2012 | 14 | 0.100 |
Why?
|
| GATA1 Transcription Factor | 1 | 2012 | 18 | 0.100 |
Why?
|
| Conserved Sequence | 1 | 2012 | 211 | 0.100 |
Why?
|
| Symbiosis | 1 | 2013 | 126 | 0.100 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2012 | 76 | 0.100 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2011 | 5 | 0.100 |
Why?
|
| Leukemia, Myeloid | 1 | 2012 | 249 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1265 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 48 | 0.100 |
Why?
|
| ErbB Receptors | 1 | 2014 | 500 | 0.100 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 62 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2012 | 165 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2014 | 3374 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 136 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2011 | 76 | 0.090 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 160 | 0.090 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 70 | 0.090 |
Why?
|
| Hypoxia | 1 | 2015 | 650 | 0.090 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 646 | 0.090 |
Why?
|
| Animals | 8 | 2015 | 27324 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 1108 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2011 | 446 | 0.090 |
Why?
|
| Janus Kinases | 1 | 2009 | 23 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 3 | 2017 | 232 | 0.080 |
Why?
|
| Proteins | 1 | 2014 | 786 | 0.080 |
Why?
|
| Drosophila Proteins | 2 | 2010 | 508 | 0.080 |
Why?
|
| Sex Factors | 1 | 2011 | 1063 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 788 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 1867 | 0.070 |
Why?
|
| Mutation | 2 | 2015 | 4132 | 0.070 |
Why?
|
| Protein Binding | 1 | 2010 | 1487 | 0.070 |
Why?
|
| Humans | 13 | 2021 | 89073 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2009 | 435 | 0.060 |
Why?
|
| Phenotype | 3 | 2015 | 2439 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 294 | 0.060 |
Why?
|
| Gene Frequency | 2 | 2015 | 685 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 635 | 0.050 |
Why?
|
| Transcriptome | 2 | 2021 | 628 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 3000 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 1768 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 3027 | 0.050 |
Why?
|
| RNA Interference | 2 | 2014 | 376 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2012 | 794 | 0.050 |
Why?
|
| Base Sequence | 2 | 2014 | 2327 | 0.050 |
Why?
|
| Male | 5 | 2015 | 42254 | 0.040 |
Why?
|
| Genes | 1 | 2021 | 305 | 0.040 |
Why?
|
| Female | 5 | 2017 | 46014 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2017 | 2011 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2015 | 1371 | 0.040 |
Why?
|
| Cell Line | 2 | 2014 | 2495 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 2062 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 114 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2017 | 274 | 0.030 |
Why?
|
| Middle Aged | 4 | 2017 | 25865 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 147 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 210 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 34 | 0.030 |
Why?
|
| Cell Size | 1 | 2015 | 68 | 0.030 |
Why?
|
| Directed Molecular Evolution | 1 | 2015 | 20 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2015 | 171 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 247 | 0.030 |
Why?
|
| Laser Capture Microdissection | 1 | 2014 | 20 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 52 | 0.030 |
Why?
|
| Thyroid Diseases | 1 | 2015 | 105 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2014 | 156 | 0.030 |
Why?
|
| Aged | 3 | 2017 | 19078 | 0.030 |
Why?
|
| DNA Primers | 1 | 2014 | 543 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 12 | 0.030 |
Why?
|
| U937 Cells | 1 | 2012 | 32 | 0.030 |
Why?
|
| K562 Cells | 1 | 2012 | 44 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 372 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 529 | 0.030 |
Why?
|
| Pedigree | 1 | 2015 | 969 | 0.030 |
Why?
|
| Yeasts | 1 | 2012 | 49 | 0.030 |
Why?
|
| Haplotypes | 1 | 2015 | 637 | 0.030 |
Why?
|
| Clinical Coding | 1 | 2012 | 24 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 557 | 0.030 |
Why?
|
| Antibodies | 1 | 2014 | 353 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 195 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 65 | 0.030 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2012 | 14 | 0.030 |
Why?
|
| Erythroid Cells | 1 | 2012 | 14 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2012 | 261 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 2012 | 36 | 0.030 |
Why?
|
| Plasmids | 1 | 2012 | 291 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 242 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2012 | 84 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 266 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 148 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 26508 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 261 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2015 | 509 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 338 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 511 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 470 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 253 | 0.020 |
Why?
|
| Methylation | 1 | 2012 | 268 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 287 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 841 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 887 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2012 | 291 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 638 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2863 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1796 | 0.020 |
Why?
|
| Histones | 1 | 2012 | 329 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 887 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2012 | 285 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 695 | 0.020 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 2009 | 5 | 0.020 |
Why?
|
| Compound Eye, Arthropod | 1 | 2009 | 7 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 3773 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2014 | 944 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2009 | 58 | 0.020 |
Why?
|
| Nervous System | 1 | 2009 | 89 | 0.020 |
Why?
|
| Mice | 2 | 2012 | 11742 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1241 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1296 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2009 | 196 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 964 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 1990 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 661 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 2553 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1975 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 308 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 1130 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6777 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 1157 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 5466 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 1145 | 0.010 |
Why?
|
| Child | 1 | 2015 | 7149 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 6289 | 0.010 |
Why?
|
| Apoptosis | 1 | 2009 | 1717 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 9237 | 0.010 |
Why?
|